Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Aerie Pharmaceuticals (NQ: AERI )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aerie Pharmaceuticals

< Previous 1 2 3 4 5 Next >
Aerie Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
From Alcon Inc. Investors
Via Business Wire
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign. 
Via Benzinga
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
From Aerie Pharmaceuticals, Inc.
Via Business Wire
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
From Kahn Swick & Foti, LLC
Via Business Wire
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
Small-cap biotech Catalyst Pharmaceuticals has been outperforming the broader market amid earnings and revenue acceleration. It joined the S&P 600 last month. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
The biotech run off a June bottom is great — until you realize you could've netted more. 
Via Investor's Business Daily
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
From Aerie Pharmaceuticals, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Upgrades 
Via Benzinga
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
From Kahn Swick & Foti, LLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022
  
Via Benzinga
Aerie Pharmaceuticals's Return On Capital Employed Overview
According to data from Benzinga Pro, during Q2, Aerie Pharmaceuticals's (NASDAQ:AERI) reported sales totaled $33.31 million. Despite a 46.03% increase in earnings, the company posted a loss of $19.37... 
Via Benzinga
AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Macy's, Palo Alto Networks And Other Big Gainers From Tuesday
U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst
Via Benzinga
Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Stocks Cut Lower As Dow Sheds Another Triple Digits
Though most sectors are suffering today, especially real estate and healthcare, energy stocks are on the rise as oil prices make a big resurgence. 
Via Talk Markets
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday. 
Via Benzinga
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Why Is Ocugen (OCGN) Stock Climbing Higher Today?
Ocugen (OCGN) stock is gaining on Tuesday after Mizuho Securities analysts initiated coverage of the medical company's shares. 
Via InvestorPlace
Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million
Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of 
Via Spotlight Growth
INTC Stock Alert: What to Know as Intel Co-Invests in Arizona Chip Factories
Intel (INTC) stock is in the news today after the company announced its co-investment into Arizona semiconductor factories. 
Via InvestorPlace
Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today?
Aerie Pharmaceuticals (AERI) stock is rising higher on Tuesday following news of a $770 million acquisition deal with Alcon (ALC). 
Via InvestorPlace
US Stocks Mixed; Dow Falls 50 Points
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022
  
Via Benzinga
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie. 
Via Investor's Business Daily
AMC Entertainment Price Target Cut By This Analyst, Plus DA Davidson Predicts $318 For Estée Lauder
DA Davidson cut the price target for The Estée Lauder Companies Inc. (NYSE: EL) from $342 to $318. Estée Lauder shares fell 0.4% to $264.29 in pre-market trading. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.